Echo Therapeutics Inc (NASDAQ:ECTE)

1.59
Delayed Data
As of May 26
 -0.03 / -1.85%
Today’s Change
0.39
Today|||52-Week Range
3.00
+17.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues19.1K19.1K0.000.00
 
 
 
Depreciation And Amortization98.9K97.9K96.0K86.7K
 
 
 
 
 
 
Operating ExpensesGross Income-----96.0K-86.7K
 
 
 
General Expenses3.8M2.8M2.7M2.3M
 
 
 
 
 
Research And Development1.7M1.2M613.4K831.3K
 
 
 
 
 
Total Operating Expenses3.9M2.9M2.8M2.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.9M-2.9M-2.8M-2.4M
 
 
 
 
 
Extraordinary Credit393.0K473.0K----
 
 
 
Extraordinary Charge0.000.00-95.0K-257.8K
 
 
 
Interest Expense On Debt243.8K3.1M0.005.5M
 
 
 
 
Other Expenses1.5K0.00-2.6K-108.8K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.8M-5.5M-2.9M-8.3M
 
 
 
 
 
Income Taxes0.000.00-4.0K--
 
 
Preferred Dividend0.000.00-350.0K--
 
 
Net Income-3.8M-5.5M-2.9M-8.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.1M12.7M12.6M11.5M
 
 
 
 
 
Shares To Calculate EPS Diluted12.1M12.7M12.6M11.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.31-$0.43-$0.26-$0.72
 
 
 
 
 
EPS Diluted-$0.31-$0.43-$0.26-$0.72
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account